Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
Sales | 6,796,000 | 6,432,000 | 6,452,000 | 5,958,000 | 6,400,000 |
Cost of Goods | 1,554,000 | 1,504,000 | 1,405,000 | 1,369,000 | 1,475,000 |
Gross Profit | 5,242,000 | 4,928,000 | 5,047,000 | 4,589,000 | 4,925,000 |
Operating Expenses | 2,928,000 | 2,567,000 | 2,660,000 | 2,311,000 | 2,812,000 |
Operating Income | 2,314,000 | 2,361,000 | 2,387,000 | 2,278,000 | 2,113,000 |
Interest Expense | 290,000 | 250,000 | 225,000 | 200,000 | 199,000 |
Other Income | -26,000 | -97,000 | -66,000 | -302,000 | 10,000 |
Pre-tax Income | 1,998,000 | 2,014,000 | 2,096,000 | 1,776,000 | 1,924,000 |
Income Tax | 607,000 | 416,000 | 486,000 | 422,000 | 407,000 |
Net Income Continuous | 1,391,000 | 1,598,000 | 1,610,000 | 1,354,000 | 1,517,000 |
Net Income | $1,391,000 | $1,598,000 | $1,610,000 | $1,354,000 | $1,517,000 |
EPS Basic Total Ops | 0.86 | 0.97 | 0.99 | 0.83 | 0.92 |
EPS Basic Continuous Ops | 0.86 | 0.98 | 0.99 | 0.84 | 0.93 |
EPS Diluted Total Ops | 0.85 | 0.97 | 0.98 | 0.83 | 0.93 |
EPS Diluted Continuous Ops | 0.86 | 0.97 | 0.99 | 0.83 | 0.93 |
EBITDA(a) | $2,642,000 | $2,665,000 | $2,676,000 | $2,546,000 | $2,374,000 |